Log in
OTCMKTS:HSDT

Helius Medical Technologies Stock Forecast, Price & News

$0.45
+0.02 (+4.68 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.43
Now: $0.45▼
$0.45
50-Day Range
$0.38
MA: $0.42▼
$0.47
52-Week Range
$0.25
Now: $0.45▼
$1.69
Volume179,025 shs
Average Volume620,203 shs
Market Capitalization$20.19 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
Read More
Helius Medical Technologies logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HSDT
Previous Symbol
CUSIPN/A
CIK1610853
Webwww.heliusmedical.com
Phone215-944-6100
Employees19

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares45,113,000
Market Cap$20.19 million
Next Earnings DateN/A
OptionableNot Optionable
$0.45
+0.02 (+4.68 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HSDT News and Ratings via Email

Sign-up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Helius Medical Technologies (OTCMKTS:HSDT) Frequently Asked Questions

How has Helius Medical Technologies' stock been impacted by Coronavirus?

Helius Medical Technologies' stock was trading at $0.5401 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HSDT shares have decreased by 17.1% and is now trading at $0.4475.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Helius Medical Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Helius Medical Technologies.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies, Inc. (OTCMKTS:HSDT) released its earnings results on Wednesday, August, 12th. The company reported ($0.08) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.12) by $0.04. The company had revenue of $0.13 million for the quarter, compared to the consensus estimate of $0.10 million.
View Helius Medical Technologies' earnings history.

What guidance has Helius Medical Technologies issued on next quarter's earnings?

Helius Medical Technologies updated its second quarter 2020 After-Hours earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100K - 100K.

Who are some of Helius Medical Technologies' key competitors?

Some companies that are related to Helius Medical Technologies include Electromed (ELMD), Electromed (ELMD), electroCore (ECOR), Fc Global Realty (FCRE), IRIDEX (IRIX), Second Sight Medical Products (EYES), ENDRA Life Sciences (NDRA), Reshape Lifesciences (RSLS), Precision Optics (PEYE), CHF Solutions (CHFS), Digirad (DRAD), Viveve Medical (VIVE), Micron Solutions (MICR), Guided Therapeutics (GTHP) and Vaso (VASO).
View all competitors.

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include Mazor Robotics (MZOR), Coty (COTY), Boxlight (BOXL), Matinas BioPharma (MTNB), Remark (MARK), Opko Health (OPK), Carnival Co. & (CCL), Energy Transfer (ET), Ocugen (OCGN) and VBI Vaccines (VBIV).

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:
  • Mr. Dane Carl Andreeff, Interim Pres & CEO and Director (Age 54)
  • Ms. Joyce N. LaViscount, CFO, COO & Sec. (Age 58, Pay $390.33k)
  • Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 62, Pay $336.55k)
  • Diane Carman, Exec. VP & Gen. Counsel
  • Dr. Brian W. Bapty Ph.D., VP of Strategy and Bus. Devel. (Age 51)

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the OTCMKTS under the ticker symbol "HSDT."

How do I buy shares of Helius Medical Technologies?

Shares of HSDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Helius Medical Technologies' stock price today?

One share of HSDT stock can currently be purchased for approximately $0.45.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of $20.19 million. Helius Medical Technologies employs 19 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is www.heliusmedical.com.

How can I contact Helius Medical Technologies?

Helius Medical Technologies' mailing address is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. The company can be reached via phone at 215-944-6100 or via email at [email protected]

This page was last updated on 10/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.